One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Multi-institutional review of non-hypospadiac penile urethral stricture management and outcomes
David Abramowitz, Andre-Philippe Sam, Mark Pachorek, Nora Ruel, Francisco Martins, Javier Angulo, Jay Simhan, Eric Li, Dmitriy Nikolavsky, Connor Policastro, Erick Ramirez-Perez, Frank Burks, Zubin Shetty, Krishnan Venkatesan, Craig Hunter, Maxx Gallegos, Jordan Foreman, Joseph Pariser, Khushabu Kasabwala, Damian Lopez, Susan Macdonald, Jonathan Warner
doi : 10.1111/iju.14786
Editorial Comment to Multi-institutional review of non-hypospadiac penile urethral stricture management and outcomes
Akio Horiguchi M.D., Ph.D.
doi : 10.1111/iju.14811
Presence of CD133-positive circulating tumor cells predicts worse progression-free survival in patients with metastatic castration-sensitive prostate cancer
Yunjie Yang, Zheng Liu, Qifeng Wang, Kun Chang, Junyu Zhang, Dingwei Ye, Yunyi Kong, Bo Dai
doi : 10.1111/iju.14801
Mirabegron for treatment of erectile dysfunction concomitant with lower urinary tract symptoms in patients with benign prostatic obstruction: A randomized controlled trial
Ramy Elbaz, Ahmed El-Assmy, Mohamed H Zahran, Abdelwahab Hashem, Ahmed A Shokeir
doi : 10.1111/iju.14792
Editorial Comment from Dr Funahashi to Mirabegron for treatment of erectile dysfunction concomitant with lower urinary tract symptoms in patients with benign prostatic obstruction: A randomized controlled trial
Yasuhito Funahashi M.D.
doi : 10.1111/iju.14819
Editorial Comment from Dr Matsuo et al. to Mirabegron for treatment of erectile dysfunction concomitant with lower urinary tract symptoms in patients with benign prostatic obstruction: A randomized controlled trial
Tomohiro Matsuo M.D., Ph.D., Yasuyoshi Miyata M.D., Ph.D., Hideki Sakai M.D., Ph.D.
doi : 10.1111/iju.14820
Efficacy of combined androgen blockade therapy in patients with metastatic hormone-sensitive prostate cancer stratified by tumor burden
Yoshiyuki Nagumo, Mizuki Onozawa, Takahiro Kojima, Naoki Terada, Masaki Shiota, Koji Mitsuzuka, Hiroaki Yasumoto, Hiroaki Matsumoto, Hideki Enokida, Takayuki Sugiyama, Kentaro Kuroiwa, Toshihiro Saito, Akira Yokomizo, Naoki Kohei, Ken-ichi Tabata, Atsushi Takahashi, Mikio Sugimoto, Hiroshi Kitamura, Toshiyuki Kamoto, Hiroyuki Nishiyama
doi : 10.1111/iju.14793
Supervised machine learning algorithm identified KRT20, BATF and TP63 as biologically relevant biomarkers for bladder biopsy specimens from interstitial cystitis/bladder pain syndrome patients
Tomohiko Kamasako, Kanya Kaga, Ken-ichi Inoue, Masanori Hariyama, Tomonori Yamanishi
doi : 10.1111/iju.14795
Editorial Comment to Supervised machine learning algorithm identified KRT20, BATF and TP63 as biologically relevant biomarkers for bladder biopsy specimens from interstitial cystitis/bladder pain syndrome patients
Tomohiro Ueda M.D., Ph.D.
doi : 10.1111/iju.14807
Comparative oncological outcomes after radical prostatectomy or external beam radiation therapy plus androgen deprivation therapy in men with clinical T3b prostate cancer
Wonchul Lee, Bumjin Lim, Yoon Soo Kyung, Choung-Soo Kim
doi : 10.1111/iju.14799
Editorial Comment to Comparative oncological outcomes after radical prostatectomy or external beam radiation therapy plus androgen deprivation therapy in men with clinical T3b prostate cancer
Takuma Narita M.D., Ph.D., Shingo Hatakeyama M.D., Ph.D., Chikara Ohyama M.D., Ph.D.
doi : 10.1111/iju.14849
Efficacy of one- and two-stage segment urethroplasty for severe chordee with congenital short urethra
Guanglun Zhou, Jianchun Yin, Junjie Sun, Zhilin Yang, Shoulin Li
doi : 10.1111/iju.14800
Editorial Comment to Efficacy of one- and two-stage segment urethroplasty for severe chordee with congenital short urethra
Mohammed Said ElSheemy M.D.
doi : 10.1111/iju.14848
Validation of models predicting lymph node involvement probability in patients with prostate cancer
Leandro Blas, Masaki Shiota, Shohei Nagakawa, Shigehiro Tsukahara, Takashi Matsumoto, Keisuke Monji, Eiji Kashiwagi, Ario Takeuchi, Junichi Inokuchi, Masatoshi Eto
doi : 10.1111/iju.14802
Is transvaginal mesh procedure a potential measure for pelvic organ prolapse repair when performed by expert surgeons?
Masami Takeyama, Tomoko Kuwata, Chikako Kato, Hiromi Kashihara, Masaki Watanabe, Rie Kinoshita, Miho Hirota
doi : 10.1111/iju.14804
Clinical features and urodynamic findings in elderly men with chronic prostatitis
Yoshihisa Matsukawa, Yasuhito Funahashi, Shohei Ishida, Yushi Naito, Takuma Yuba, Kazuna Matsuo, Momokazu Gotoh
doi : 10.1111/iju.14805
Importance of considering interest in sex when evaluating satisfaction after robot-assisted radical prostatectomy
Yuki Kohada, Jun Ito, Yasuhiro Kaiho, Hiroki Kusumoto, Takashi Kukimoto, Jotaro Mikami, Nobuyuki Hinata, Makoto Sato
doi : 10.1111/iju.14813
Editorial Comment to Importance of considering interest in sex when evaluating satisfaction after robot-assisted radical prostatectomy
Nobuhiro Haga M.D., Ph.D., Takeshi Miyazaki M.D., Naotaka Gunge M.D., Hiroshi Matsuzaki M.D., Yu Okabe M.D.
doi : 10.1111/iju.14842
Complications and their management following retroperitoneal lymph node dissection in conjunction with retroperitoneal laparoscopic radical nephroureterectomy
Toru Kanno, Go Kobori, Katsuhiro Ito, Hiromichi Nakagawa, Toshifumi Takahashi, Naoto Takaoka, Shinya Somiya, Kanji Nagahama, Masaaki Ito, Yuzuru Megumi, Yoshihito Higashi, Seiji Moroi, Toshiya Akao, Hitoshi Yamada
doi : 10.1111/iju.14814
Early dynamics of circulating tumor DNA predict clinical response to immune checkpoint inhibitors in metastatic renal cell carcinoma
Yoko Koh, Kosuke Nakano, Kotoe Katayama, Gaku Yamamichi, Satoru Yumiba, Eisuke Tomiyama, Makoto Matsushita, Yujiro Hayashi, Yoshiyuki Yamamoto, Taigo Kato, Koji Hatano, Atsunari Kawashima, Takeshi Ujike, Ryoichi Imamura, Rui Yamaguchi, Seiya Imoto, Yukimasa Shiotsu, Norio Nonomura, Motohide Uemura
doi : 10.1111/iju.14816
Clinical and emotional factors for the acceptance or refusal of deceased-donor kidney transplantation in patients on waiting lists during the coronavirus disease 2019 pandemic
Shunta Hori M.D., Ph.D., Mitsuru Tomizawa M.D., Tatsuo Yoneda M.D., Ph.D., Yasushi Nakai M.D., Ph.D., Makito Miyake M.D., Ph.D., Kiyohide Fujimoto M.D., Ph.D.
doi : 10.1111/iju.14798
Residue and recurrence in percutaneous cryoablation for cT1 renal tumor: Clinical utility and feasibility of salvage cryoablation with iodized oil marking
Takafumi Yanagisawa M.D., Ph.D., Jun Miki M.D., Ph.D., Kanichiro Shimizu M.D., Ph.D., Kenji Motohashi M.D., Keitaro Enoki M.D., Shin Egawa M.D., Ph.D.
doi : 10.1111/iju.14809
Totally intracorporeal urinary diversion under robot-assisted surgery may not increase the incidence and risk factors of surgical site infection
Manabu Takai M.D., Kota Kawase M.D., Daiki Kato M.D., Koji Iinuma M.D., Keita Nakane M.D., Ph.D., Takuya Koie M.D., Ph.D.
doi : 10.1111/iju.14810
Effect of upfront combination therapy on the overall survival of patients with metastatic castration-sensitive prostate cancer: A multicenter retrospective study
Toshikazu Tanaka M.D., Shingo Hatakeyama M.D., Ph.D., Daisuke Noro M.D., Kyo Togashi M.D., Takahiro Yoneyama M.D., Chikara Ohyama M.D.
doi : 10.1111/iju.14817
Editorial Comment to Effect of upfront combination therapy on the overall survival of patients with metastatic castration-sensitive prostate cancer: A multicenter retrospective study
Masaki Shiota M.D., Ph.D.
doi : 10.1111/iju.14864
